Literature DB >> 29318453

Sensory neuronopathy heralding human T cell lymphotropic virus type I myelopathy.

Alberto R M Martinez1, Raphael F Casseb1, Carlos R Martins1, Anamarli Nucci1, Marcondes C França2.   

Abstract

Neurological phenotypes of human T cell lymphotropic virus type I (HTLV-1) are numerous and rarely may not manifest the classic HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP). We report a case of HTLV-1-related sensory neuronopathy heralding the classic HAM/TSP.

Entities:  

Keywords:  Ganglionopathy; HTLV; HTLV-1 myelopathy; Sensory neuronopathy

Mesh：

Year:  2018        PMID： 29318453     DOI： 10.1007/s13365-017-0609-x

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


  10 in total

Review 1.  The HTLV-1 neurological complex.

Authors:  Abelardo Q C Araujo; Marcus Tulius T Silva
Journal:  Lancet Neurol       Date:  2006-12       Impact factor: 44.182

2.  Chronic sensory neuronopathy associated with human T-cell lymphotropic virus type I infection.

Authors:  Rie Shimazaki; Hidetsugu Ueyama; Toshio Mori; Miyuki Mori; Shin Fujimoto; Toshihide Kumamoto; Tomiyasu Tsuda
Journal:  J Neurol Sci       Date:  2002-02-15       Impact factor: 3.181

3.  Update on Neurological Manifestations of HTLV-1 Infection.

Authors:  Abelardo Q-C Araujo
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

Review 4.  Human T-lymphotropic virus 1: recent knowledge about an ancient infection.

Authors:  Kristien Verdonck; Elsa González; Sonia Van Dooren; Anne-Mieke Vandamme; Guido Vanham; Eduardo Gotuzzo
Journal:  Lancet Infect Dis       Date:  2007-04       Impact factor: 25.071

5.  Peripheral nerve lesions in HTLV-I associated myelopathy (HAM/TSP).

Authors:  A I Bhigjee; P L Bill; C A Wiley; I M Windsor; D A Matthias; T Amenomori; W Wachsman; D Moorhouse
Journal:  Muscle Nerve       Date:  1993-01       Impact factor: 3.217

6.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

Review 7.  Sensory neuron diseases.

Authors:  Angelo Sghirlanzoni; Davide Pareyson; Giuseppe Lauria
Journal:  Lancet Neurol       Date:  2005-06       Impact factor: 44.182

8.  Pyramidal tract degeneration in multiple system atrophy: the relevance of magnetization transfer imaging.

Authors:  Antonio José da Rocha; Antonio Carlos Martins Maia; Carlos Jorge da Silva; Flávio Túlio Braga; Nelson Paes Diniz Fortes Ferreira; Orlando Graziani Povoas Barsottini; Henrique Ballalai Ferraz
Journal:  Mov Disord       Date:  2007-01-15       Impact factor: 10.338

9.  Sensory neuronopathy and autoimmune diseases.

Authors:  Alberto R M Martinez; Marcelo B Nunes; Anamarli Nucci; Marcondes C França
Journal:  Autoimmune Dis       Date:  2012-01-19

10.  The pattern and diagnostic criteria of sensory neuronopathy: a case-control study.

Authors:  Jean-Philippe Camdessanché; Guillemette Jousserand; Karine Ferraud; Christophe Vial; Philippe Petiot; Jérôme Honnorat; Jean-Christophe Antoine
Journal:  Brain       Date:  2009-06-08       Impact factor: 13.501
  10 in total
  1 in total

Review 1.  The ataxic neuropathies.

Authors:  Stéphane Mathis; Fanny Duval; Antoine Soulages; Guilhem Solé; Gwendal Le Masson
Journal:  J Neurol       Date:  2020-06-15       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.